SOLICITATION NOTICE
B -- Development of Hepatitis C Virus-Like Particles
- Notice Date
- 9/3/2008
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 621511
— Medical Laboratories
- Contracting Office
- National Institutes of HealthNational Institute of Diabetes andDigestive and Kidney Diseases6707 Democracy Blvd., Room 779BethesdaMD20892-7511
- ZIP Code
- 20892-7511
- Solicitation Number
- NIHDK2008133
- Response Due
- 9/12/2008
- Archive Date
- 10/12/2008
- Point of Contact
- HAUN, PATRICIA M +1 301 594 8855, haunp@extra.niddk.nih.gov<br />
- Small Business Set-Aside
- N/A
- Description
- This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation and a separate written solicitation will not be issued. This solicitation number is NIHDK-2008133, and is issued as a Request for Quotation (RFQ). The solicitation/contract will include all applicable provisions and clauses in effect through Federal Acquisition Circular 2005-26. The North American Industry Classification (NAICS) Code is 621511 and the business size standard is $12.5M. However, this solicitation is not set aside for small business. This acquisition is being conducted using Simplified Acquisition Procedures in accordance with FAR Part 13. The National Institutes of Health (NIH), National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) intends to contract on a sole source basis with Southwest Foundation for Biomedical Research, PO Box 760549, San Antonio, TX 78245 for the housing and maintenance services of chimpanzees. These services are for the development of Hepatitis C Virus-like particles as a candidate HCV vaccine in chimpanzees. The service shall include the following: 1) An AAALAC approved facility for performing the proposed experiments on chimpanzees and housing them for appropriate follow-up; 2) Infect/transfect animals; obtain and store bleedings as well as tissue specimens at appropriate temperatures; perform biopsies, ultrasound and other diagnostic procedures; and obtain other specimens which shall be examined for existence of infection and used for various studies; 3) Perform tests of liver enzyme(s) functions, routine blood and clinical chemistry analyses, and other serological markers and diagnostic tests relating to the development of complications of virus infection such as chronic disease and cancer; 4) Prepare, process and provide evaluation of liver and other tissue specimens including, but not limited to, (histo) pathology of liver to determine disease progression, growth and a variety of viral studies, and perform apheresis to obtain large volume of peripheral lymphocytes and plasma; 5) With approval, send the above tests to established laboratories for determination; 6) House all infected and experimental animals in isolation so that cross-infection or contamination of animals does not occur. Containment of experimental animals in isolation chambers shall be required for the duration of their protocols; and 7) Provide proper veterinary diet, water, electrolytes, and medication for all animals in accordance with the standard prescribed by appropriate Government guidelines and the Project Officer. The Contractor shall be part of the NIH Primate Facilities, that has been approved for use by the NIH Interagency Animal Model Committee, and that are sanctioned for use by NIDDK. The period of performance is for one (1) year. The proposed contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under authority of the 41 U.S.C. 253(c)(1), FAR 6.302. This notice of intent is not a request for competitive quotations however, all responses received, within 10 days from the date of publication of this synopsis will be considered by the Government. The offeror must include a completed copy of the provision of FAR Clause 52.212-3, Offeror Representations and Certifications Commercial Items with its offer. The provisions of FAR Clause 52.212-1 Instructions to Offerors Commercial Items; FAR Clause 52.212-2, Evaluation Commercial Items; FAR Clause 52.212-4, Contract Terms and Conditions Commercial Items; and FAR 52.212-5, Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items Deviation for Simplified Acquisitions applies to this acquisition. The offeror must include in their Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. The clauses are available in full text at http://www.arnet.gov/far. Interested vendors capable of furnishing the government with the service specified in this synopsis should submit their quotation to the below address. Quotations will be due ten (10) calendar days from the publication date of this synopsis or September 12, 2008. The quotation must reference Solicitation number NIHDK-2008133. All responsible sources may submit a quotation, which if timely received, shall be considered by the agency. Quotations must be submitted in writing to the National Institute of Diabetes and Digestive and Kidney Diseases 6707 Democracy Blvd., Room 779, Bethesda, Maryland 20817, Attention: Patricia Haun. Faxed copies will not be accepted.
- Web Link
-
FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=84314b67b3453f80647bc1fc84e01b2d&tab=core&_cview=1)
- Record
- SN01658527-W 20080905/080903223823-84314b67b3453f80647bc1fc84e01b2d (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |